← SynDRA
ADP-597
SynDRA canonical compound SYN0028733 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | GPR119 |
|---|
| Mechanism of action | glucose dependent insulinotropic receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CYP2C9
- ADGRF1
- HDAC6
- SMUG1
- S1PR1
- OGG1
- NEIL2
- NEIL1
- MUTYH
- MPG
- MBD4
- KCNH2
- GPR35
- ADRA2A
- GLP1R
- FPR2
- FFAR4
- CX3CR1
- C5AR1
- APLNR
- AGTR1
- ADRB2
- TDG
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- JNJ-38431055
- APD-597
- APD597
- JNJ 38431055
- UNII-345354O7AT
- APD597 (JNJ-38431055)
- JNJ38431055
- APD 597
- APD597(JNJ-38431055)
- SCHEMBL386884
- GTPL5727
- orb1304457
- SCHEMBL29645341
- C21H29N5O6S
- WPDCHTSXOPUOII-UHFFFAOYSA-N
- GLXC-05922
- EX-A1213
- BDBM50364559
- AKOS026751481
- CS-5278
- SB16860
- NCGC00508849-03
- AC-33177
- BS-17790
- HY-15566
- DB-109001
- NS00072236
- C77029
- BRD-K86226872-001-01-6
Look up ADP-597 in the interactive SynDRA portal →